November, 15 2025 Saturday 23:31 Hrs
  • SENSEX :   84,562.78

  • Commodity broking firm in India84.11( 0.10%) 14-Nov-2025

IPO Synopsis

Mahamaya Lifesciences Ltd
Initial public offer of up to 61,78,800 equity shares of face value of Rs. 10/- each ("Equity shares") of Mahamaya Lifesciences Limited ("MLL" or the "Company") for cash at price of Rs. 114 per equity share (including a share premium of Rs.94 per equity share) (the "Offer Price"), aggregating up to Rs. 70.44 Crore ("the Offer"), comprising a fresh offer of upto 56,38,800* equity shares aggregating to Rs. 64.28 Crore (the "Fresh Offer") and an offer for sale of upto 540,000* equity shares (the "Offered Shares") of face value of Rs. 10/- each aggregating up to Rs. 6.16 Crore ("offer for sale") comprising of 3,70,000* equity shares aggregating up to Rs. 4.22 Crore by Krishnamurthy Ganesan and 1,70,000* equity shares aggregating up to Rs. 1.94 Crore by Lalitha Krishnamurthy (collectively reffered to as the "Selling Shareholders") out of which 3,09,600 equity shares of face value Rs. 10/- each, at an offer price of Rs. 114 per equity share for cash, aggregating Rs. 3.53 crores will be reserved for subscription by the market maker to the offer (the "Market Maker Reservation Portion"). The offer less market maker reservation portion i.e. net offer of 58,69,200* equity shares of face value of Rs. 10/- each, at an offer price of Rs. 114 per equity share for cash, aggregating up to Rs. 66.91 crores is hereinafter referred to as the "Net Offer". The offer and net offer will constitute 26.40% and 25.08% respectively of the post-offer paid-up equity share capital of the company.
Issue
Opens On Closes On
11-Nov-25 13-Nov-25
Money Payable On
Application Allotment
114.00 0.00
Minimum Application for shares in Nos : 2400 Further Multiples of : 1200
(.Cr) Lead Managers to the Issue
Project Cost (.Cr) 0.00 Oneview Corporate Advisors Pvt Ltd
Project Financed through Current Offer (.Cr) 70.44  
Post Issue Equity Share Capital (.Cr) 23.41
Issue Price () 114.00
Projects
Purchase of equipment for existing formulation plant
Funding capital expenditure towards setting up of a new technical manufacturing plant
Construction of warehouse building and purchase of machinery
Funding working capital requirement of the company
General corporate purposes
Promoted By
Krishnamurthy Ganesan
Lalitha Krishnamurthy
Prashant Krishnamurthy
Listing At
BSE - SME
Registrar to the Issue
KFin Techologies Ltd
Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.